OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prebiotic Lactulose Ameliorates the Cognitive Deficit in Alzheimer’s Disease Mouse Model through Macroautophagy and Chaperone-Mediated Autophagy Pathways
Yan-Suan Lee, Dar-Ming Lai, Hei-Jen Huang, et al.
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 8, pp. 2422-2437
Closed Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders
Shokufeh Ghasemian Sorboni, Hanieh Shakeri Moghaddam, Reza Jafarzadeh Esfehani, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 1
Open Access | Times Cited: 307

The different autophagy degradation pathways and neurodegeneration
Angeleen Fleming, Mathieu Bourdenx, Motoki Fujimaki, et al.
Neuron (2022) Vol. 110, Iss. 6, pp. 935-966
Open Access | Times Cited: 285

The Potential Role of Gut Microbiota in Alzheimer’s Disease: From Diagnosis to Treatment
Angelica Varesi, Elisa Pierella, Marcello Romeo, et al.
Nutrients (2022) Vol. 14, Iss. 3, pp. 668-668
Open Access | Times Cited: 158

Roles and Mechanisms of Gut Microbiota in Patients With Alzheimer’s Disease
Shaochang Wu, Xia Liu, Ruilai Jiang, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 105

The Role of Microbiome in Brain Development and Neurodegenerative Diseases
Varsha Nandwana, Nitesh Kumar Nandwana, Yogarupa Das, et al.
Molecules (2022) Vol. 27, Iss. 11, pp. 3402-3402
Open Access | Times Cited: 76

The gut microbiome and Alzheimer’s disease: Complex and bidirectional interactions
Rawan Tarawneh, Elena Penhos
Neuroscience & Biobehavioral Reviews (2022) Vol. 141, pp. 104814-104814
Open Access | Times Cited: 49

Disaccharide trehalose in experimental therapies for neurodegenerative disorders: Molecular targets and translational potential
А. Б. Пупышев, T. P. Klyushnik, Anna A. Akopyan, et al.
Pharmacological Research (2022) Vol. 183, pp. 106373-106373
Closed Access | Times Cited: 46

The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment
Angelica Varesi, Lucrezia Irene Maria Campagnoli, Foroogh Fahmideh, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12289-12289
Open Access | Times Cited: 45

Linking circadian rhythms to microbiome-gut-brain axis in aging-associated neurodegenerative diseases
Wai‐Yin Cheng, YS Ho, Raymond Chuen‐Chung Chang
Ageing Research Reviews (2022) Vol. 78, pp. 101620-101620
Closed Access | Times Cited: 38

Gut-brain axis through the lens of gut microbiota and their relationships with Alzheimer's disease pathology: Review and recommendations
L. Krishaa, Ted Kheng Siang Ng, Hai Ning Wee, et al.
Mechanisms of Ageing and Development (2023) Vol. 211, pp. 111787-111787
Open Access | Times Cited: 29

Gut Microbiota and Alzheimer’s Disease: How to Study and Apply Their Relationship
Ngoc Minh Nguyen, Jungsook Cho, Choongho Lee
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4047-4047
Open Access | Times Cited: 22

Gut microbiota-host lipid crosstalk in Alzheimer’s disease: implications for disease progression and therapeutics
Yaxi Luo, Ling-Ling Yang, Xiu‐Qing Yao
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 13

Nutrition, Gut Microbiota, and Alzheimer's Disease
Mariana Romanenko, Victor Kholin, Alexander Koliada, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 43

Targeting gut microbiota to alleviate neuroinflammation in Alzheimer’s disease
Vu Thu Thuy Nguyen, Kristina Endres
Advanced Drug Delivery Reviews (2022) Vol. 188, pp. 114418-114418
Closed Access | Times Cited: 34

Convergent pathways of the gut microbiota–brain axis and neurodegenerative disorders
Carolina Gubert, Juciano Gasparotto, Lívia H. Morais
Gastroenterology report (2022) Vol. 10
Open Access | Times Cited: 28

Targeting autophagy in Alzheimer’s disease: Animal models and mechanisms
Xiaowen Zhang, Xiangxing Zhu, Dongsheng Tang, et al.
动物学研究 (2023) Vol. 44, Iss. 6, pp. 1132-1145
Open Access | Times Cited: 18

Tactics with Prebiotics for the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease via the Improvement of Mitophagy
Ai Tsuji, Sayuri Yoshikawa, Yuka Ikeda, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5465-5465
Open Access | Times Cited: 16

Impacts of oxidants and antioxidants on the emergence and progression of Alzheimer's disease
Hamieh Goshtasbi, Parvin Samadi Pakchin, Ali Movafeghi, et al.
Neurochemistry International (2021) Vol. 153, pp. 105268-105268
Closed Access | Times Cited: 34

Protective Effects of Polysaccharides in Neurodegenerative Diseases
Yinying Wang, Rongsha Chen, Zhongshan Yang, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 23

Role of microbial dysbiosis in the pathogenesis of Alzheimer's disease
Gudimetla Susmitha, Rahul Kumar
Neuropharmacology (2023) Vol. 229, pp. 109478-109478
Closed Access | Times Cited: 15

Gut microbiome-based therapies for alleviating cognitive impairment: state of the field, limitations, and future perspectives
Linli Bu, Chen Wang, Junying Bai, et al.
Food & Function (2024) Vol. 15, Iss. 3, pp. 1116-1134
Closed Access | Times Cited: 5

Epigenetics in Alzheimer’s Disease: A Critical Overview
Chiara Villa, Romina Combi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5970-5970
Open Access | Times Cited: 5

Molecular mechanism and therapeutic strategy of bile acids in Alzheimer’s disease from the emerging perspective of the microbiota–gut–brain axis
Menglu Wu, Yongyi Cheng, Ruolin Zhang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117228-117228
Open Access | Times Cited: 4

Page 1 - Next Page

Scroll to top